1. In a retrospective review of patient data from 12 hospices in the US, 16.3% of cancer patients experience late hospice care (length of stay <3 days).
2. Hematologic malignancies, male sex, age <65 years were risk factors for late hospice admission.
Evidence Rating Level: 3 (Average)
Study Rundown: Despite the known benefits associated with hospice care towards the end-of-life, including improved quality of life and reduction in caregiver stress, many cancer patients do not receive this care until very close to death. The purpose of this study was to evaluate the factors that put patients at risk for late hospice admissions through a retrospective review of electronic patient records of 12 hospices in the US. At the conclusion of this retrospective cohort study, the authors found that late admission (defined as length of stay <3 days) occurred in 1 in 6 (16%) cancer patients admitted to hospice care. Risk factors for late admission included being male, married, age <65 years, and a diagnosis of hematologic malignancy. Furthermore, patients with Medicaid or self-insurance were at decreased risk for late admission. Based on these findings, the authors suggested that these factors may be used to identify patients at risk and to develop programs to reduce late admissions. However, the study only analyzed data from not-for-profit hospices, which may reduce the generalizability of the result.
Click to read the study in JCO
Relevant Reading: Hospice use and high-intensity care in men dying of prostate cancer
In-Depth [retrospective cohort]: This was a retrospective cohort study that included 64,264 patients admitted to 12 hospices in the Coalition of Hospices Organized to Investigate Comparative Effectiveness (CHOICE) network. The reviewed demonstrated that 10,460 (16.3%) cancer patients admitted to hospice care had a length of stay <3 days, with significant variation among hospices, ranging from 11.4% to 24.5% late hospice admissions. Using multi-variate analysis, patient factors predicting late admission included hematologic malignancy (OR: 1.52; 95% CI: 1.41-1.64), male gender (OR: 1.22; 95% CI: 1.16-1.28), presence of a spouse (OR: 1.23; 95% CI: 1.17-1.29), and age >65 years (OR: 0.90; 95% CI: 0.82-0.97). Self-insured patients (OR: 0.74; 95% CI: 0.66-0.84) and Medicaid patients (OR: 0.83; 95% CI: 0.76-0.91) were at a decreased risk for late hospice admission compared to Medicare or commercial insurance.
More from this author: Rituximab linked with reduced chronic immune disease following stem cell transplantation, High-dose prophylaxis for hemophilia increases costs with minimal benefit, Ambrisentan found ineffective against idiopathic pulmonary fibrosis
Image: PD
©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.
